Alexion to buy Synageva BioPharma in $8.4 billion deal
Alexion Pharmaceuticals will buy rival Synageva BioPharma in an $8.4 billion cash-and-stock deal that will bolster Alexion`s business in treatments for rare diseases, the US companies announced Wednesday.
May 06, 2015, 21:27 PM IST